APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease
Kenny W.J Lee, Amir F Ayyobi, Jiri J Frohlich, John S HillVolume:
176
Year:
2004
Language:
english
DOI:
10.1016/j.atherosclerosis.2004.04.024
File:
PDF, 95 KB
english, 2004